Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.100
-0.060 (-5.17%)
At close: Mar 20, 2026, 4:00 PM EDT
1.080
-0.020 (-1.82%)
After-hours: Mar 20, 2026, 7:41 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $143.51 million as of March 20, 2026. Its market cap has increased by 38.54% in one year.
Market Cap
143.51M
Enterprise Value
128.61M
1-Year Change
38.54%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $143.51M, a decrease of -41.09%. That is a compound annual growth rate of -7.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 143.51M | 123.55% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 150.41M |
| Heron Therapeutics | 146.80M |
| Humacyte | 146.61M |
| Codexis | 145.39M |
| Unicycive Therapeutics | 144.64M |
| AN2 Therapeutics | 143.76M |
| Agenus | 142.46M |
| vTv Therapeutics | 141.79M |